Quality Assurance Intern – Compliance & Systems

Regeneron Pharmaceuticals; Rensselaer (IN); On-site; USD 25,000 - 35,000; Full time

Job summary

Regeneron Pharmaceuticals invites qualified students to join our Quality Assurance – Compliance & Quality Systems internship program. These full-time, on-site roles in the Rensselaer/East Greenbush/Troy area support deviation analysis, change management, and regulatory readiness through desk-based work and cross-functional collaboration.

You will develop documentation templates, job aids, and training materials while gaining exposure to regulatory submissions and health authority information

Qualifications

• Must be enrolled in an Undergraduate or Graduate degree program and returning to school the semester following the position or graduating after the position.
• Cumulative GPA of 3.0 or higher preferred.
• Majors listed above are relevant for internship eligibility.

Responsibilities

• Analyze deviation, exception and quality-signal data to identify trends.
• Develop standard language, trackers and templates for audit-ready documentation.
• Support change management, product quality reviews and regulatory submissions.
• Create tools and guides for QA reviewers and cross-functional teams.
• Collaborate across functions; roles are largely desk-based with strong communication.

Skills

Organizational skills

Communication skills

Leadership

Education

Biology

Chemistry

Pharmacy

Biomedical Engineering

Chemical Engineering

Mechanical Engineering

Computer Science/IT

Statistics/Data Science

Supply Chain/Industrial Engineering

Job description

Regeneron Pharmaceuticals invites qualified students to join our Quality Assurance – Compliance & Quality Systems internship program. These full-time, on-site roles in the Rensselaer/East Greenbush/Troy area support deviation analysis, change management, and regulatory readiness through desk-based work and cross-functional collaboration.

You will develop documentation templates, job aids, and training materials while gaining exposure to regulatory submissions and health authority information